NCT01125514View on ClinicalTrials.gov

A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Heart Failure
Interventions
DRUG

Aliskiren 150 mg

Aliskiren 150 mg tablet

DRUG

Furosemide 60 mg

Furosemide 60 mg commercially-available tablets

DRUG

Placebo for Aliskiren

Matching placebo for aliskiren 150 mg and 300 mg

DRUG

Aliskiren 300 mg

Aliskiren 300 mg tablet

Trial Locations (2)

Unknown

Novartis Investigative Site, Berlin

Novartis Investigative Site, Vilnius

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY